Erasca Stock Quote ERAS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.3477

Bid

3.20

Ask

3.35

Volume

1,377,770

3.20 Day's Range 3.45

1.51 52 Week Range 3.45

Market Cap

580.354M

Previous Close

3.27

Open

3.35

Last Trade

3.3499

Last Trade Time

19:03:59

Financial Volume

$ 4,539,077

VWAP

3.2945

Average Volume (3m)

2,531,255

Shares Outstanding

173,358,966

Dividend Yield

PE Ratio

-4.55

Earnings Per Share (EPS)

-0.72

Revenue

Net Profit

-125.04M

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.erasca.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was $3.27. Over the last year, Erasca shares have traded in a share price range of $ 1.51 to $ 3.45.

Erasca currently has 173,358,966 shares outstanding. The market capitalization of Erasca is $566.88 million. Erasca has a price to earnings ratio (PE ratio) of -4.55.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.3277	10.8509933775	3.02	3.45	2.94	1480613	3.10149725	CS
4	1.0077	43.0641025641	2.34	3.45	2.1	2651850	2.81647839	CS
12	1.1277	50.7972972973	2.22	3.45	1.81	2531255	2.47763747	CS
26	1.6277	94.6337209302	1.72	3.45	1.64	1565493	2.38026179	CS
52	0.8277	32.8452380952	2.52	3.45	1.51	1216223	2.27871605	CS
156	-15.8523	-82.5640625	19.2	24.47	1.51	851675	5.07799259	CS
260	-12.5523	-78.9452830189	15.9	24.47	1.51	855173	5.23795549	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CGTXCognition Therapeutics Inc	$ 3.47 (46.41%)	4.6M
NAMSNewAmsterdam Pharma Company NV	$ 22.49 (19.25%)	18.82k
RNAZTransCode Therapeutics Inc	$ 0.341 (15.36%)	6.61M
YYGHYY Group Holding Ltd	$ 0.84 (14.60%)	743
YIBOPlanet Image International Ltd	$ 3.32 (13.89%)	56.73k
VTVTvTv Therapeutics Inc	$ 13.00 (-38.68%)	33.14k
CEROCERo Therapeutics Holdings Inc	$ 0.1669 (-34.80%)	3.51M
TGLTreasure Global Inc	$ 1.32 (-28.65%)	53.49k
LUXHLuxUrban Hotels Inc	$ 0.1587 (-16.91%)	1.31M
RGCRegencell Bioscience Holdings Ltd	$ 10.69 (-13.02%)	14.55k
SLNASelina Hospitality PLC	$ 0.0281 (-6.33%)	23.11M
RNAZTransCode Therapeutics Inc	$ 0.341 (15.36%)	6.61M
CGTXCognition Therapeutics Inc	$ 3.47 (46.41%)	4.6M
TLTiShares 20 plus Year Treasury Bond	$ 92.94 (-0.05%)	3.9M
CEROCERo Therapeutics Holdings Inc	$ 0.1669 (-34.80%)	3.51M